A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung

BACKGROUND: Recent advances have shown that histology and genetic biomarkers are important in patient selection, which have led to significantly better outcomes for lung cancer patients. However, most new treatments only apply to adenocarcinoma or non-squamous, and in squamous carcinoma there is lit...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Yang, Jin-Ji, Huang, Cheng, Chen, Gong-Yan, Song, Yong, Cheng, Ying, Yan, Hong-Hong, Zhou, Qing, Wu, Yi-Long
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Study Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4179224/
https://ncbi.nlm.nih.gov/pubmed/25239521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-684
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki